Sign up to get updates from us
In this episode, VibeCast host Ray Dogum speaks with Bryan Vought, PhD and John McShane from the Boston Epigenics Society about advancing epigenetics and revolutionizing technology in biotech. -------------------------- Key moments: 00:00:06 - Introduction to Vibecast 00:01:47 - The Genesis of the Boston Epigenetics Society 00:04:20 - Understanding Epigenetics 00:07:52 - Value of the Boston Epigenetics Society 00:10:34 - Unique Qualities of Boston for Biotechs 00:15:34 - Job Market Trends 00:17:45 - Industry Shifts 00:18:28 - Strategic Partnerships 00:21:27 - Biotech Financing 00:24:00 - Event Promotion Guest Bios: Bryan Vought- I completed my PhD in biophysics at Syracuse University. I came to Boston in 2000 to do my post-doc research at Harvard Medical School. From there I was hired as a protein biochemist/biophysicist at Vertex Pharmaceuticals to focus on membrane proteins. Later in my career, I became Director of in vitro biology at Ring Therapeutics where we use human primary and IPSC cell models to better understand how anellovirus can be harnessed to provide genetic therapy to patients. While I was at Alkermes, I met John McShane. We were both passionate about epigenetics. The pandemic was keeping people apart, and we thought about how we might bring people together to talk about and promote epigenetics. We talked through different ideas about how we might do that. From that, the Boston Epigenetics Society was born. We would host webinars and bring together people while promoting epigenetics. John McShane has worked the last 12 years in biotech commercialization and business development focusing on epigenetic and next generation sequencing. He holds a Masters in Biotech Management from the Katz School of Science and Health at Yeshiva University and a Bachelors Degree in Molecular Biology from Lehigh University. He is currently the director of business development at Biomodal, a precision multiomics company backed by google ventures. John is a co-founder and steering committee member of the Boston Epigenetics Society. The Boston Epigenetic Society has been founded to: - Promote epigenetics and epitranscriptomics research - Foster connections between academics and industry epigenetics scientists - Help promote new methods - Create a support system for experimental epigenetics research Guest Links: Bryan Vought Linkedin: https://www.linkedin.com/in/bwvought/ John McShane Linkedin: https://www.linkedin.com/in/john-mcshane-ms-32764b39/ About VibeCast VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation. Guests include biotech founders, regulatory experts, drug development executives, blockchain technologists, web3 community builders, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments. Follow Vibe Bio's Socials: https://twitter.com/VibeBio https://www.linkedin.com/company/vibe-bio/ https://www.instagram.com/vibebiotechnology/ https://www.tiktok.com/@vibebio https://www.facebook.com/VibeBiotechnology/ Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and the statements of our guests reflect their personal views only and do not necessarily reflect the views or positions of any agency, organization, or company that they work for or are affiliated with.
